Moyer, P., Leguay, T., Huguet, F., Roth-Guepin, G., Hicheri, Y., Belhabri, A., Cluzeau, T., Berceanu, A., Tavernier, E., Lepretre, S., Bilger, K., Turlure, P., Bastie, J., Balsat, M., Alexis, M., Brissot, E., Lebon, D., Raffoux, E., Wickenhauser, S., Cacheux, V., Banos, A., Bonnet, S., Boissel, N., Dombret, H., Jullien, M., Rousselot, P., Chevallier, P. (2025). Outcome after relapse in older patients with Philadelphia Chromosome–Negative B-cell ALL treated with inotuzumab ozogamicin and low-dose chemotherapy in first-line therapy: A graall study. Blood. https://doi.org/10.1182/blood-2025-3340